Nordic Pharma Consulting ApS: Financial statements 2025
CVR: 37368598
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Nordic Pharma Consulting ApS (CVR 37368598) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. That is an increase of 12.8% compared with the year before. Equity in the 2025 report amounted to DKK 4,487,385. The solvency ratio was 56.6%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 15,902,080
- Profit/Loss
- DKK 3,684,788
- Equity
- DKK 4,487,385
- Total Assets
- DKK 7,927,046
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 15.9M | 3.7M | 4.5M | 10 |
| 2024 | - | 14.1M | 3M | 3.8M | 8 |
| 2023 | - | 11.2M | 1.6M | 2.4M | 7 |
| 2022 | - | 11.6M | 3.6M | 4.4M | 6 |
| 2021 | - | 8.8M | 1.8M | 2.6M | 6 |
Official annual report
How creditworthy is Nordic Pharma Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Nordic Pharma Consulting ApS has published its annual report for 2024. Gross profit came to DKK 14,101,873, and the net result was DKK 2,966,376.
About Nordic Pharma Consulting ApS
Nordic Pharma Consulting ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2016. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Thomas Bill Madsen and Ray David Sossna. The company is owned by Bill Holding ApS and by.david ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 15,902,080 and a net result of DKK 3,684,788 compared with DKK 2,966,376 the year before. Equity in the 2025 report amounted to DKK 4,487,385.